FECH and autosomal erythropoietic protoporphyria: The discovery that clinical expression of this type of EPP normally required a hypomorphic FECH IVS3-48C allele trans to the mutation was demonstrated in France [26,31] and was independently confirmed by studies from Japan, North America, Sweden, Israel, South Africa, the United Kingdom [28,30-34].